Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Aqua Bio Technology AGM Information 2023

Jun 9, 2023

3535_mrq_2023-06-09_6fe5c737-fe69-43a8-a07d-dff4b2468637.html

AGM Information

Open in viewer

Opens in your device viewer

Aqua Bio Technology ASA: Disclosure of proxies for the annual general meeting

Aqua Bio Technology ASA: Disclosure of proxies for the annual general meeting

9.6.2023 10:19:26 CEST | Aqua Bio Technology ASA | Major shareholding

notifications

The chairman of the board of directors of Aqua Bio Technology ASA (the "Company"

or "ABT"), Jan Olav Ødegård, has received proxies with and without voting

instructions to vote for shares in the Company at the annual general meeting on

9 June 2023 ("AGM"). In addition to the 300 shares Jon Olav Ødegård owns through

his wholly owned subsidiary Ødegård Prosjekt AS, Jon Olav Ødegård is eligible to

vote for 12,966,129 shares in the Company at the AGM, representing 62,06 % of

the shares and votes in the Company.

This information is subject to the disclosure requirements pursuant to sections

4-2 and 5-12 of the Norwegian Securities Trading Act.

For further information, please contact Håvard Lindstrøm, CEO, telephone +47 941

32 288.

* * *

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. ABT's focus on commercialization and development of natural

ingredients and natural skin care products has been, and will continue to be, an

important part of the Company's strategy going forward. ABT is listed on the

Euronext Expand market of the Oslo Stock Exchange.

DISCLOSURE REGULATION

This information is subject of the disclosure requirements pursuant to section

of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Håvard Lindstrøm, 004794132288, [email protected]

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable

biotechnology for use in skin care products. ABT's cosmetics ingredients are

highly effective and they provide the cosmetics industry with natural

alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and

professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

Download announcement as PDF.pdf -

https://kommunikasjon.ntb.no/ir-files/17847556/2426/3368/Download%20announcement

%20as%20PDF.pdf